# Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules

> **NCT02958696** · PHASE1 · COMPLETED · sponsor: **Nxera Pharma UK Limited** · enrollment: 37 (actual)

## Conditions studied

- Bioavailability and Pharmacokinetics

## Interventions

- **DRUG:** HTL0018318

## Key facts

- **NCT ID:** NCT02958696
- **Lead sponsor:** Nxera Pharma UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02958696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02958696, "Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02958696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*